advancing-precision Admera Health Homepage

Genetic tests provide actionable results and guide
important and time sensitive health decisions

PGxOnePlus_RxVision_DuoLogo2 Admera Health Homepage


Admera Health’s Clinical Decision Support System

  • Gain digital access to all patients’ PGxOne™ Plus results even without an EMR integration
  • Easily navigate test results with dynamic searches, including by medication, therapeutic area, and drug interactions
  • Securely and easily refer a patient’s report to another physician
db685702-daa6-4bd4-b3f0-b76e9dc5f552 Admera Health Homepage

Everyone responds to
medications differently

Admera’s PGxOne™ Plus test informs physicians of treatments based on genetics

Over 60 genes | Over 200 variants
8ae8ca5e-c998-453a-8ac9-27290eb1d81b Admera Health Homepage

Everyone responds to
medications differently

Admera’s PGxOne™ Plus test informs physicians of treatments based on genetics

Over 50 genes | Over 200 variants

Learn More

dr_questions_icon_2.2 Admera Health Homepage A courtesy consultation with experts in the field of pharmacogenomics is available Monday through Friday 8am to 8pm EST at phone_icon_call_center Admera Health Homepage 844-4ADMERA (844.423.6372)

PGxOne_Plus_respond_to_medications Admera Health Homepage

Everyone responds to medications differently

Admera’s PGxOne™ Plus test informs physicians of treatments based on genetics

Over 50 genes | Over 200 variants

Learn More

What is Pharmacogenomics?

pharmacogenomics_icon Admera Health Homepage
Pharmacogenomics (PGx) combines the study of genetics with the science of drug delivery.

PGxOne™ Plus provides actionable reporting

PGxOne_Plus_icon Admera Health Homepage The PGxOne™ Plus report provides gene, genotype, and PGx related phenotype information providing an additional tool to manage patient care.

Learn More >

What is Pharmacogenomics?

pharmacogenomics_icon Admera Health Homepage Pharmacogenomics (PGx) combines the study of genetics with the science of drug delivery.

PGxOne™ Plus provides actionable reporting.

PGxOne_Plus_icon Admera Health Homepage The PGxOne™ Plus report provides gene, genotype, and PGx related phenotype information providing an additional tool to manage patient care.

Learn More >

OncoPortfolio_logo_web_small_2 Admera Health Homepage

Genetic testing that spans the continuum of patient care

Learn More
Bitmap Admera Health Homepage

OncoPortfolio_logo_web_small_2 Admera Health Homepage

Genetic testing that spans the continuum of patient care

Learn More

LiquidGx

Liquidgx_non_invasive_cancer_icon Admera Health Homepage Non-invasive cancer testing for identifying
actionable mutations and treatment
monitoring from a blood sample.

Learn More >

OncoGxOne™ – Solid Tumor Profiling

Solid_Tumor_Icon Admera Health Homepage Tumor profiling for targeted therapy selection. Choose between a panel aligned with national treatment guidelines or a comprehensive panel.

Learn More >

LiquidGx

Liquidgx_non_invasive_cancer_icon Admera Health Homepage Non-invasive cancer testing for identifying actionable mutations and treatment monitoring from a blood sample.

Learn More >

Solid Tumor Profiling

Solid_Tumor_Icon Admera Health Homepage Tumor profiling for targeted therapy selection. Choose between a panel aligned with national treatment guidelines or a comprehensive panel.

Learn More >

CardioPortfolio_logo_web_small_2 Admera Health Homepage

Comprehensive genetic testing for inherited cardiovascular diseases

Learn More
cardiology2 Admera Health Homepage

CardioPortfolio_logo_web_small_2 Admera Health Homepage

Comprehensive genetic testing for inherited cardiovascular diseases

Learn More

AtheroGxOne™

atheroGxOne_icon Admera Health Homepage Detects genetic variants responsible
for diseases that can cause early
atherosclerosis.

Learn More >

CardioGxOne™

atheroGxOne_icon Admera Health Homepage Detects genetic variants responsible for over 30 inherited cardiovascular diseases included cardiomyopathies, arrhythmias, and aortic vascular diseases.

Learn More >

AtheroGxOne™

atheroGxOne_icon Admera Health Homepage Detects genetic variants responsible for diseases that can cause early atherosclerosis.

Learn More >

CardioGxOne™

atheroGxOne_icon Admera Health Homepage Detects genetic variants responsible for over 30 inherited cardiovascular diseases included cardiomyopathies, arrhythmias, and aortic vascular diseases.

Learn More >

1

Provide a buccal swab,
mouth wash, blood,
or saliva sample

Sample_Type_Table_New-x2-e1598409425566 Admera Health Homepage

2

Ship the
specimen to
Admera Health

how_it_works_2 Admera Health Homepage

3

Admera Health
scientists sequence
and interpret DNA

how_it_works_3 Admera Health Homepage

4

Receive a
personalized
genetic report

how_it_works_4 Admera Health Homepage

Massive Bio to Present SYNERGY-AI Trial-in-Progress Poster Presentation at Upcoming AACR 2019 using its AI Clinical Trial Matching Technology, and Announces Strategic Partnership in Precision Oncology with US-Based Admera Health

NEW YORK, April 02, 2019 (GLOBE NEWSWIRE) -- Massive Bio, Inc., a leader in providing simplified and affordable access to clinical trials and precision oncology to cancer patients treated at community-based oncology practices, announced today that its Trials-in-Progress poster titled “SYNERGY-AI: Artificial intelligence based precision oncology clinical trial matching and [...]

Load More Posts
Go to Top